Calderdale and Huddersfield NHS Foundation Trust

HPS to manufacture medicines for phase IIB psychosis treatment clinical trial

Huddersfield Pharmacy Specials (HPS) is delighted to announce that the business has been selected to formulate and manufacture active and placebo medicines for a pragmatic, multicentre, randomised controlled trial of active versus placebo in patients clinically at high-risk of developing psychosis. HPS will be responsible for and advising upon the investigational medicinal product dossier (IMPD), […]

HPS welcomes involvement in NHS Scientist Training Programme (STP)

HPS is helping to support several trainees on the national postgraduate training scheme for the next generation of healthcare scientists. A large range of specialisms are offered spanning the physiological, physical and life sciences. Healthcare scientists are helping to drive innovation and new technologies within the NHS. Although comprising a mere 5% of the total […]

HPS to manufacture medicines for major paediatric clinical trial

Huddersfield Pharmacy Specials (HPS) is delighted to announce that the business has been selected to manufacture active and placebo medicines for a large scale Multicentre, Parallel Randomised Controlled Trial to examine treatments to reduce anxiety in children attending for elective surgery. HPS will be responsible for and advising upon the investigational medicinal product dossier (IMPD), […]

MP Tours Specialist Unit at CHFT

Huddersfield MP Barry Sheerman recently toured the pioneering Pharmacy Manufacturing Unit (PMU) based at the Calderdale and Huddersfield NHS Foundation Trust which is at the forefront of research to save lives through organ transplantation. A special solution is currently being developed in labs there to preserve human organs which have been removed and are awaiting […]

HPS wins contract to research, develop and manufacture novel organ preservation fluid

Huddersfield Pharmacy Specials (HPS) is delighted to announce that it has won a multi-year contract research project to research, develop and manufacture a novel fluid designed to improve the viability of donor human organs, such as liver and kidney, that have been removed for pending transplant into recipients. As well as research and development, HPS […]

Sign up to our newsletter to receive regular updates about our new products
  • CHFT